Australia markets closed

Sanofi (SNYNF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
112.50+10.35 (+10.13%)
At close: 11:40AM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in EUR. All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
40,342,000
39,175,000
37,369,000
37,631,000
35,677,000
Cost of revenue
12,451,000
12,255,000
12,157,000
11,976,000
11,435,000
Gross profit
27,891,000
26,920,000
25,212,000
25,655,000
24,242,000
Operating expenses
Research development
5,915,000
5,692,000
5,529,000
6,018,000
5,894,000
Selling general and administrative
9,740,000
9,555,000
9,390,000
9,883,000
9,859,000
Total operating expenses
18,405,000
17,773,000
17,319,000
18,429,000
17,987,000
Operating income or loss
9,486,000
9,147,000
7,893,000
7,226,000
6,255,000
Interest expense
392,000
403,000
436,000
444,000
435,000
Total other income/expenses net
-1,016,000
-1,016,000
6,248,000
-4,101,000
-1,579,000
Income before tax
8,144,000
7,798,000
13,804,000
2,822,000
4,405,000
Income tax expense
1,486,000
1,558,000
1,813,000
139,000
481,000
Income from continuing operations
6,718,000
6,279,000
12,350,000
2,938,000
4,423,000
Net income
6,666,000
6,223,000
12,314,000
2,806,000
4,306,000
Net income available to common shareholders
6,666,000
6,223,000
12,314,000
2,806,000
4,306,000
Basic EPS
-
-
9.82
2.24
3.45
Diluted EPS
-
-
9.82
2.24
3.45
Basic average shares
-
-
1,253,600
1,249,900
1,247,100
Diluted average shares
-
-
1,253,600
1,249,900
1,247,100
EBITDA
-
11,552,000
17,924,000
10,718,000
9,119,000